A national study of plasma use in critical care: clinical indications, dose and effect on prothrombin time
Critical Care2011Vol. 15(2), pp. R108–R108
Citations Over TimeTop 1% of 2011 papers
Simon Stanworth, Timothy Walsh, R.J. Prescott, Robert J. Lee, Douglas Watson, Duncan Wyncoll, the Intensive Care Study of Coagulopathy (ISOC) investigators
Abstract
There is wide variation in FFP use by ICU clinicians, and a high proportion of current FFP transfusions are of unproven clinical benefit. Better evidence from clinical trials could significantly alter patterns of use and modify current treatment costs.
Related Papers
- Susquehanna Chorale Spring Concert "Roots and Wings"(2017)
- → DETERMINING QUALITY REQUIREMENTS AT THE UNIVERSITIES TO IMPROVE THE QUALITY OF EDUCATION(2018)
- → Genentech taps Affimed’s antibodies(2018)
- Enxerto livre de arteria epigastrica inferior: avaliacao hemodinamica e angiografica pre e pos-operatoria(1988)
- → KOMPLIKASI REGIONAL ANESTESI PADA PEDIATRIK(2023)